NU-BLOG
Happenings and perspectives from Nusano and our collaborators
Talk Radioisotopes: Dr. Luke Nordquist, Founder & CEO of XCancer
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate...
Talk Radioisotopes: Matt Furlow, Associate Principal & Head of the ZS Radiopharmaceutical Center of Excellence
On this episode, hosts Scott Larrivee and Sarah Scouten are joined by Matt Furlow, Associate Principal & Head of the Radiopharmaceutical Center of Excellence at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering...
Nusano CEO Chris Lowe on A Dose of Reality Podcast
Nusano CEO Chris Lowe appears on the A Dose of Reality podcast hosted by Charles Spence. The two discuss: 04:51 Proudest Moment of Chris in his Career and Leadership Philosophy 07:41 Nusano: Innovations in Medical Radioisotope Production 13:55 Building a Talented Team...
Talk Radioisotopes: Prof. Suzanne Lapi, University of Alabama at Birmingham
On this episode, hosts Scott Larrivee and Sarah Scouten sit down with Dr. Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham. The conversation dives into Dr. Lapi’s multifaceted role in...
Talk Radioisotopes: Shamar Young, TeleDaaS
On this episode of the Talk Radioisotopes podcast, hosts Scott and Sarah are joined by Dr. Shamar Young, Chief Medical Officer at TeleDaaS and Division Chief of Interventional Radiology at the University of Arizona. The discussion explores Dr. Young’s journey into...
Nusano Featured in Salt Lake Business Journal
March 14, 2025 – Nusano's radioisotope production platform is profiled in a Salt Lake City Business Journal article: Chris Lowe, company CEO, said the origin of Nusano was “to address the underlying problems that have plagued national research labs and countries’...
Talk Radioisotopes: Bruno Paquin, AtomVie
In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma.Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussion highlights AtomVie’s role as a leading contract...
Nusano Named Researcher of the Year at Inaugural Best of BioHive Awards
[dsm_image_carousel gallery_ids="292288,292284,292285,292287,292286,292280" sizes="thumbnail" lazyload="on" centered_slides="on" autoplay_speed="4000" show_lightbox="on" _builder_version="4.27.4" _module_preset="default" global_colors_info="{}"...
Talk Radioisotopes: Arjun Murthy, Maven Bio
On this episode of Talk Radioisotopes, hosts Scott Larrivee and Sarah Scouten interview Arjun Murthy, co-founder of Maven Bio, an AI-driven biopharma market intelligence platform. They explore how Arjun's background, along with Maven Bio's technology, is transforming...
Talk Radioisotopes: Shaemus Gleason, Clarity Pharmaceuticals
On this episode, Talk Radioisotopes hosts Scott Larrivee and Sarah Scouten sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus's journey through the radiopharmaceutical industry, Clarity's innovations,...